AI In-Brief

Thailand News in Brief

Thai PBS World

Thailand and the world, every day

AI can make mistakes. Please double-check.

Respiratory disease specialist objects to BMA plan to administer Favipiravir to all COVID-19 patients

13 Sept 08:07 Key points summarised by AI

Dr. Nitipat Jiarakul, President of the Thoracic Society of Thailand, strongly opposes the Bangkok Metropolitan Administration's (BMA) plan to administer the Favipiravir anti-viral drug to all COVID-19 patients in field hospitals.
Favipiravir was initially approved in Thailand for severe COVID-19 lung infections under special circumstances, based on the belief it could reduce symptom severity, despite a lack of scientific evidence from Western use.
Dr. Nitipat's primary objections stem from concerns over potential drug shortages for patients who critically need it, the risk of doctors becoming complacent and relying solely on the drug, and the significant danger of the virus developing drug resistance due to non-rationed use.

Today 16:46 Key points summarised by AI

A dinner between Bhumjaithai and Kla Tham party leaders sparked rumors of a potential merger, though Bhumjaithai's leader, Anutin, downplayed it as a casual meal.
The meeting is widely interpreted as a strategic message from Bhumjaithai to the Pheu Thai party, signaling alternative support ahead of an upcoming no-confidence debate.
Thailand's Constitution (Section 99) currently prohibits direct mergers of parties with sitting MPs during the House's term, a rule designed to prevent the 'buying and selling' of MPs.
While direct mergers are restricted, MPs can still switch parties if dismissed by a three-fourths party vote or if their party dissolves, allowing for indirect political realignments.
Kla Tham's voting behavior in the censure debate will demonstrate its loyalty to the government, potentially influencing future political dynamics despite current merger restrictions.